KO

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✓

Return

+0.32%

Status

scored

Maintain KO at current weight with ~3.4% annualized carry (2.47% dividend + ~1% covered call premium) as the explicit alpha source, neither chasing the $87-88 area into Q3 earnings nor trimming directionally. The two consecutive Underweight failures at the $85.67 lower Bollinger Band, combined with 26.4× P/E at 85th-percentile and negative MACD (-0.317), make a pre-committed 5-10% tactical trim into any $87.50 relief bounce the operative action when cumulative alpha approaches -1.0%, while the post-earnings add zone at $85-86 requires MACD bullish cross on volume confirmation.

Outcome

✗

Return

+2.27%

Status

scored

Maintain KO at current weight with ~3.4% annualized carry (2.46% dividend + Dec 90 covered call premium) as the explicit alpha source; pre-commit to a tactical 5-10% reduction only if relief bounce to $87.50 occurs when cumulative alpha approaches -1.0%. Hard stop at $78.40 weekly close (200 SMA) or $85.45 close on volume, with Q3 2026 earnings (mid-October) as the binding binary reassessment point.

Outcome

✓

Return

-0.41%

Status

scored

Maintain KO at 3-4% portfolio weight with HOLD rating; do not add at current $85.50-$87 levels due to stretched valuation (25.9x P/E, 85th-percentile band) and deteriorating tactical momentum (price below 10 EMA and 50 SMA, MACD negative, RSI declining to 43). The recommended action is staged-scaling with three pre-committed add levels ($83-84, $80-81, $78-80) to build toward 6-7% maximum weight as the technical picture confirms or denies the correction thesis, rather than binary entry at $78-80.

Outcome

✓

Return

-0.39%

Status

scored

Coca-Cola is rated Underweight with a recommendation to trim 15-20% of the existing position (not the aggressive 25-40% or insufficient 10-15% proposed by other analysts). The trade should be executed in two tranches: first at $86-87 on relief bounces into the $87.50 zone, and second on confirmed 50 SMA reclaim above $87.66 with RSI>50 and positive MACD. Hard stops are set at $83.50 with full invalidation at $78.40 weekly close. The 2.48% dividend yield and defensive characteristics warrant preserving 80-85% of the position, with redeployment 50/50 into short-duration Treasuries and select defensives under 20x P/E.

Outcome

✗

Return

+1.00%

Status

scored

Maintain KO at current weight with carry-plus-premium (~3.4% annualized via 2.46% dividend plus ~1% Dec 90 covered call premium) as the explicit alpha source; five-way analyst convergence on Hold is binding. The novel action is a pre-committed 5-10% tactical trim into any relief bounce toward the 50 SMA at $87.50 the moment cumulative alpha approaches -1.2%, directly addressing the compressed-vol slow-bleed pattern that produced -1.3% to -0.2% alpha across recent Hold iterations. Dual underperformance caps (-1.5% rolling over 4-6 weeks OR -2.0% cumulative over 30 days, with time-based cap now primary) provide interim accountability, with binding reassessment at Q3 2026 earnings (late October).

Outcome

✓

Return

-0.52%

Status

scored

Maintain KO at current weight with carry-only return (~2.44% dividend, ~3.4% annualized with Dec 90 covered call overlay) as the explicit alpha source. Do not add at current $86.20 level due to stretched 3.91 PEG, bearish MACD cross, RSI at 40.7, and price below four of five moving averages; do not trim into $87.50-88.50 as that zone is the defined entry trigger, not a trim zone. Activate Dec 90 covered call overlay to monetize vol compression and boost effective carry to ~3.4% annualized.

Outcome

✓

Return

+0.02%

Status

scored

Maintain KO at Hold with carry-only return (2.44% dividend annualized) as the explicit alpha source; activate Dec 90 covered call overlay (~1% premium on compressed vol) to monetize vol compression and boost carry-plus-premium to ~3.4-3.5% annualized—this is cost-of-carry adjustment, not directional bet. No directional trim; no fresh adds at $86. Dual underperformance caps (rolling -1.5% over 4-6 weeks OR cumulative -2.0% over 30 days) now PRIMARY with Q3 2026 earnings (late October) as binding binary reassessment gate.

Outcome

✗

Return

-0.88%

Status

scored

Maintain KO at current weight with carry-only return (2.43% annualized dividend) as the explicit alpha source, rejecting both tactical adds at $86-87 and waiting for pullback to $82-85 zone with confirmed momentum reversal. The five-party analyst convergence on HOLD is binding, validated by nine prior Hold iterations, with dual underperformance caps (rolling -1.5% over 4-6 weeks OR cumulative -2.0% over 30 days) serving as the primary reassessment triggers and Q3 2026 earnings (late October) as the binding binary gate.

Outcome

✓

Return

-0.39%

Status

scored

Maintain KO at Hold with carry-only return (2.41% annualized dividend) as the explicit alpha source; reject aggressive deployment above $87.18 due to asymmetric risk setup (~3% upside vs ~11% downside) combined with PEG ~4, bearish MACD across 22+ sessions, and IRS binary catalyst in Q4 2026-Q2 2027 window. The Neutral Analyst's conditional framework with pre-staged 15-20% trim triggers above $90.10-$91.44 and binding dual underperformance caps (rolling -1.5% over 4-6 weeks AND cumulative -2.0% over 30 days) replaces the rejected $86.40 stop with structurally sound $85.45 stop (1 ATR below 50 SMA).

Outcome

✓

Return

-0.72%

Status

scored

Consensus across Research Manager, Trader, Conservative Analyst, and Neutral Analyst converges on HOLD given 26x P/E at 85th-percentile valuation with 22-session negative MACD and near-term IRS binary risk (Q4 2026 – Q2 2027). Fresh deployment is rejected on five binding constraints; carry-only return (2.41% dividend annualized) is the explicit alpha source. Stop widened to $85.45 (1 ATR below 50 SMA) to accommodate volatility expansion; 15-20% trim pre-staged on volume-confirmed push above $90-$91.44 ahead of the IRS window. Dual underperformance caps (-1.5% rolling alpha over 4-6 weeks OR -2.0% cumulative over 30 days) force reassessment on alpha decay rather than waiting for catalysts.

Outcome

✓

Return

-0.33%

Status

scored

Maintain KO at HOLD with carry-only return expectation (2.41% annualized dividend) as the explicit alpha source while widening the stop to $85.45 to avoid ATR-based noise harvesting; entry triggers are tranched (add half at $83-85 with RSI<45, add remaining half on confirmed breakout above $89.37 with positive MACD histogram on volume >20M shares), with a binding -1.5% alpha vs SPY underperformance cap over any rolling 4-6 week window and Q3 2026 earnings (late October) as the binary reassessment gate.

Outcome

✓

Return

+0.01%

Status

scored

Maintain existing KO position with carry-only return expectation (2.4% dividend annualized). Do NOT add at current levels—wait for $82-85 pullback zone, confirmed breakout above $91.44 on volume >20-day average by 50%+, or forward P/E compression to ~22x. Trim 15-20% into volume-confirmed push above $90.10-$91.44. Hard invalidation at close below $78.40 (200 SMA). Embed the -1.5% alpha vs SPY over any rolling 4-6 week window underperformance cap. Q3 2026 earnings (late October) is the binding binary gate.

Outcome

✓

Return

-0.59%

Status

scored

Maintain KO at Hold rating with the empirically validated 9/21 underperformance cap mechanism intact (+1.7% alpha validated). Add only on momentum confirmation (daily close ≥50 SMA with volume >20M, MACD histogram positive, RSI >50), trim 5-7% on volume-confirmed close above $90 with RSI >60 (not on level test), and reassess to Underweight if KO closes at $85.50 on rising volume or underperforms SPY by -1.5% over any rolling 4-6 weeks without the add trigger firing.

Outcome

✗

Return

+1.71%

Status

scored

Maintain KO at benchmark weight with carry-only return expectation (2.4% dividend annualized) while embedding a binding underperformance-tolerance cap that forces reassessment if KO underperforms SPY by -1.5% over any rolling 4-6 week window without the add trigger firing. Add on pullbacks via EITHER close above $87.94 on volume >20M shares OR successful retest of $86.02 with bullish reversal on declining volume; trim 15-20% on close above $90.50 with volume >25M shares; hard stop at close below $78.50.

Outcome

✗

Return

-1.28%

Status

scored

Maintain KO at HOLD with explicit carry-only return expectation of 2.4% annualized dividend, rejecting both aggressive addition and conservative trimming calls. The 3:1 downside-to-upside asymmetry (downside to $78.13 vs. upside to $91-92), PEG 4.2 at upper historical bound, and rolling momentum deterioration rule out Buy/Overweight, while franchise quality floor (42% ROE, 63-year dividend streak, AAA credit) and Q2 2026 reacceleration rule out Underweight/Sell. Pre-commit to Q3 2026 earnings (late October) as the binding binary reassessment gate.

Outcome

✗

Return

+0.22%

Status

scored

Trim 25-30% of the KO position via staged limit orders in the $89.50-$91.00 zone to move to Underweight versus benchmark, with the Research Manager's 25-40% range serving as the anchor. The technical setup validates the trim, with MACD down 81% from its August peak, RSI rolled from 73 to 52, and a 3:1 downside-to-upside asymmetry (11% to 200 SMA vs ~3-4% to upper Bollinger). Hard stop reference at $82 on the remaining position, with binding reassessment at Q3 2026 earnings (late October).

Outcome

✓

Return

+0.22%

Status

scored

Maintain KO at current weight with explicit carry-only return expectation (2.4% dividend annualized). Do not add at current levels; trim 10-15% on volume-confirmed push to $91-92. Apply tiered stop: soft review at close below 50 SMA ($86.35), hard trim at $83.50, full re-evaluation below 200 SMA ($78.04). Q3 2026 earnings (late October) is the binding binary gate.

Outcome

✓

Return

-0.95%

Status

scored

Maintain KO at Hold as the consensus of five analysts reflects symmetric risk between bull and bear cases. Collect the 2.4% dividend as pay-to-wait through Q3 2026 earnings, with tiered re-entry at $86.66 (lower Bollinger/50 SMA confluence with MACD/RSI confirmation) and full conviction at $80-82 (200 SMA region). Trim 25-33% on any volume-confirmed push to $92-95, using a tactical close-based stop at $85.30.

Outcome

✓

Return

-0.72%

Status

scored

Maintain Coca-Cola (KO) at HOLD with no new capital deployment above $88, instead collecting the 2.4% dividend as pay-to-wait through the Q3 2026 earnings gate in late October; re-enter the $86.00–$87.00 tier on weakness or confirm a breakout above $90.36 with volume and momentum confirmation before adding at ~50% of primary scale-in size with an $88.50 stop.

Outcome

✗

Return

+1.20%

Status

scored

Maintain KO at Hold. With P/E at the 85th percentile (26.5x) and deteriorating momentum (negative-deepening MACD, below short-term MAs), fresh capital above $87 is not warranted. Tiered accumulation is recommended at $86.50 for 30% of intended sizing and $84.50 for 70%, with a hard stop at $84.00; reassess at Q3 2026 earnings (late October).

Outcome

✓

Return

+0.52%

Status

scored

All five analysts converge on HOLD for KO as stretched valuation (26.38x P/E at 85th percentile, PEG ~4.0) conflicts with elite franchise quality (42.05% ROE, 64-year dividend streak), creating a coiled range between $86.41 support and $89-92 resistance that neither bull nor bear case can resolve directionally. The decision tightens the add-on-breakout trigger from 25-50% to 10-15% requiring both above-average volume AND MACD histogram positive for ≥2 sessions, defers any trim until confirmed push above $92.49 on heavy volume, and maintains stop at $84.80.

Outcome

✓

Return

+0.32%

Status

scored

All three risk analysts converge on HOLD for KO, with the decision anchored to stretched valuation (26x P/E at 85th percentile, PEG 4.0), deteriorating momentum (7 sessions negative MACD histogram, below 10 EMA), and near-zero residual alpha from prior Holds—but offset by intact multi-timeframe trend stack, unmatched franchise quality (42.05% ROE, 64-year dividend growth), and macro tailwinds favoring pricing-power compounders. The binding tactical architecture replaces the trader's invalid $85.30 entry-stop with a $85.50 review-level and $84.80 close-based stop, mandates no fresh capital deployment at $87.55, and conditions tiered re-entry on momentum confirmation, with Q3 2026 earnings (late October) serving as the binary reassessment gate.

Outcome

–

Return

-0.92%

Status

scored

Trim KO 10-15% near $87-89 to express directional caution while avoiding the 9/2 oversizing mistake; re-enter at $85-86 with MACD histogram confirmation or on breakout above $92.50 with volume exceeding 25M shares, with the catastrophic stop at $84.50 and Q3 2026 earnings as the binding reassessment gate.

Outcome

✓

Return

+0.33%

Status

scored

Maintain KO at benchmark weight with no fresh capital deployment above $88. The Q3 2026 earnings (late October) serves as a binding binary reassessment gate, with pre-committed rules: trim 25-33% pre-print if RSI ≤50, MACD histogram negative, or price below 10 EMA; hold through if all three are positive. Upgrade to Overweight if Q3 organic revenue exceeds +4%; downgrade to Underweight if below +2%.

Outcome

✓

Return

-0.83%

Status

scored

Maintain KO at benchmark weight (HOLD) with no fresh capital deployment above $88.81; collect the 2.4% dividend as pay-to-wait. Re-engage on pullback to $85.40-$86.00 with multi-factor confirmation (2-session hold, volume confirmation, MACD histogram flattening), or trim on breakout above $92.50 sustained for 2-3 sessions. Mandatory reassessment at Q3 2026 earnings (mid-October).

Outcome

–

Return

+0.65%

Status

scored

Analysts unanimously recommend trimming 25% of KO exposure near $88.24 given demanding valuation (26.5x P/E, 4.0x PEG, 33% S&P premium) against weak 2.75% revenue growth and a 166% FCF payout ratio, with price below both the 10 EMA ($89.06) and VWMA ($89.51) signaling bearish momentum; the 25% reduction balances harvesting risk against KO's defensive strengths (64-year dividend growth, 42% ROE, $15.81B liquidity) warranting a neutral-to-underweight rather than full exit. Reassess after 3-6 months with staged re-entry targets at $82-84 on momentum stabilization or $77-80 after confirmed reversal, and reconsider the Underweight rating only on a close above $92.20 with 1.5x 20-day average volume and positive MACD histogram.

Outcome

✓

Return

+0.27%

Status

scored

Maintain the Hold rating on KO at current levels ($88) without deploying fresh capital, as the prior 8/26 Underweight trim already captured available directional alpha. Fresh entries should be staged on pullback to the $82-85 zone (50 SMA to upper support band) with positive MACD histogram divergence, or on confirmed momentum reversal (10 EMA reclaim, RSI >55). The Q3 2026 earnings print (mid-October) serves as the binary reassessment catalyst, with a stop at $77.51 (200 SMA) protecting against catastrophic structural breaks.

Outcome

✓

Return

-0.76%

Status

scored

Analysts unanimously recommend HOLD on KO at $88.67, preserving existing exposure without new capital deployment. Fresh entries are staged on pullbacks to $85-87 (50 SMA at $85.22) rather than chasing at current all-time-high-adjacent levels, with a conditional breakout add above $92.49 above 25M volume and positive MACD expansion. Stop architecture sits at $84.50 for structural reassessment and $77.42 (200 SMA) as catastrophic stop, with full re-evaluation at Q3 2026 earnings in late October.

Outcome

✗

Return

-1.10%

Status

scored

Maintain KO at benchmark weight at $89.66, as the 8/26 directional underweight thesis was already harvested with -1.8% alpha via a 10-15% trim at $89-91, making further trimming or fresh deployment unjustified at current valuations (PEG 4.41x, 26.9x trailing P/E, 270bps yield gap to 30Y Treasury). Q3 2026 earnings in mid-October serves as the binary reassessment catalyst, with upgrade pathway above +4% organic revenue and downgrade pathway below +2% organic revenue.

Outcome

✓

Return

+0.67%

Status

scored

Maintain existing KO position after the 8/26 Underweight trim (10-15% reduction at $89-91 that captured -1.8% alpha). Q2 2026 fundamentals were exceptional with revenue +6.7%, net income +16.1%, EPS +17%, FCF +51%, and operating margin expansion from 28% to 34.9%, alongside $9.3B net debt paydown in 12 months. However, valuation is stretched (PEG 4.41x, forward P/E 25.26x, 270bps yield gap vs 30Y UST at 5.2%), momentum is decelerating (MACD histogram at 0.01, RSI cooled from 73 to 56), and a binary Jackson Hole event creates asymmetric risk — quality is too high to sell but macro/valuation too stretched to add.

Outcome

–

Return

-1.13%

Status

scored

The decision establishes a calibrated Underweight stance on KO with a 10-15% trim at $89-91, rejecting both the trader's 20-25% trim and full Sell framing as empirically oversized relative to prior decision history. Core exposure of 85-90% is retained given KO's 0.34-beta convexity and intact multi-timeframe trend stack ($89.39/$84.49/$76.86), with proceeds redeployed into short-duration Treasuries pending confirmed basing or MACD/RSI signals; stop is tightened to $84-85 (50 SMA) rather than the $76 anchor.

Outcome

✓

Return

-1.70%

Status

scored

Trim KO 30-33% from $90.50, retaining 67-70% core position, as the 27.5x trailing P/E and $3.5B annual FCF shortfall present downside risk despite the dividend compounder thesis. Set stops at $88.29 (20 SMA) with re-engagement targets at $84-86 and $80-82, subject to Q3 2026 earnings reassessment.

Outcome

–

Return

-0.38%

Status

scored

Underweight rating maintained with a tactical allocation shift: trim 20-30% of any existing position near $91.99 while retaining 70-80% core exposure for the dividend and trend. Do not initiate new positions at current price; consider staged re-entry around $84-85 (50-SMA cluster) with $80 as a secondary level only if trend is damaged but recoverable.

Outcome

✓

Return

+0.98%

Status

scored

Maintain KO at $91.10 with no fresh capital deployment, as the current 25.8x forward P/E with PEG 4.35 and 270bps gap versus 30Y Treasury at >5% does not justify new positions. Deploy tiered contingency adds of 2% at $87.50–88.50 on a confirmed 10 EMA retest, and another 2% at $84–85 only if the 50 SMA ($84.29) holds and macro conditions remain stable, with a hard stop at $84.29 close. Reassess on Q3 2026 earnings in October, clean breakout above $91.87 on >25M share volume, or close below $84.29.

Outcome

✓

Return

+0.66%

Status

scored

Maintain KO at current levels as all three analysts converge on HOLD; preserve the 2.35% dividend stream, 64-year growth streak, and structural floor (42% ROE, 0.34 beta) while awaiting a pullback to $87.50/$84.50 for staged entry with 10-15% sizing given stretched valuation (PEG 4.35, P/E 27x). Tighten stop to ~$87 (ATR-based) to protect against the 5-8% typical pullback while avoiding the structural-break threshold; trim 15% only on a push to $93-95 with RSI >75.

Outcome

✗

Return

+0.17%

Status

scored

Reduce KO exposure by trimming approximately 20% of the position at $90.35 into the $90-92 demand zone, moving to Underweight from market weight. The rating reflects stretched valuation (27x trailing P/E, 4.23 PEG, decade-high P/S), asymmetric risk/reward (~5-7% upside vs 10-16% downside), and late-cycle technicals (RSI near 70, price at upper Bollinger Band near $91.15, within 0.6% of 52-week high), though the 64-year dividend streak, 0.34 beta, $15.8B cash, and 42% ROE justify retaining 80% of the position as portfolio insurance. Re-engagement is targeted at $85-87 (10 EMA/20 EMA convergence zone) with a hard stop at $82 (50 SMA break), with trim proceeds directed to cash/short-duration Treasuries rather than higher-risk assets.

Outcome

✗

Return

+1.72%

Status

scored

Analysts recommend trimming approximately one-third of the KO long position at $88.50-$89.00 into strength, retaining two-thirds for dividend income, while explicitly rejecting new capital deployment at current valuations due to poor 1:1 risk/reward, negative expected value, stretched 26.7x P/E and 4.23 PEG ratios, and early MACD divergence despite the structural Dividend King thesis remaining intact.

Outcome

✗

Return

+2.12%

Status

scored

Maintain HOLD on KO at ~$87 with a calibrated 10-15% starter add (reduced from prior 25-33% due to elevated PEG of 4.23) to break the pattern of "patience without re-engagement." Tiered adds preserved at $83.50-$84.00 (half-size) and $78-$80 (full-size), with trim guidance above $90.60-$90.92. Reassess at Q3 2026 earnings in October.

Outcome

✓

Return

-0.83%

Status

scored

Maintain HOLD on KO at ~$87 with an explicit 25-33% starter add at current levels to break the four-cycle "patience without re-engagement" failure mode that produced -0.2% to +0.0% alpha across prior HOLDs; validated by the 2026-08-13 +0.5% alpha capture. Tiered adds reserved for confirmed weakness at $84.50-$85.50 (10 EMA) and $82.00-$82.85 (50 SMA retest), with stop at $76.00 and trim guidance 10-15% above $90.60-$90.92 on volume confirmation. Reassess at Q3 2026 earnings in October.

Outcome

✓

Return

+0.33%

Status

scored

Maintain HOLD on KO at $87.42 with a corrective commitment to a 25–33% starter add at current levels to break the four-consecutive-HOLD failure pattern that produced -0.2%, -0.1%, +0.0%, and +0.1% alpha respectively. The rating reflects convergence among all three analysts: fortress fundamentals (28.6% net margins, 42% ROE, 62 years of dividend growth) support continued ownership, but 26x trailing P/E at 12–15% above the 10-year norm and a PEG of 4.18 versus S&P's 2.0–2.3 argue against full addition at all-time-high resistance with flatlined momentum.

Outcome

✓

Return

+0.82%

Status

scored

Maintain HOLD on KO at $86.71 as all three analysts converge, with valuation (26.04x trailing P/E, 24.59x forward P/E, 10.32x book, 4.19 PEG) and technical deterioration (seven consecutive lower highs, MACD histogram at -0.09) arguing against adding at current levels despite exceptional Q2 2026 fundamentals (42% ROE, +16.3% net income growth, record $1.03 EPS, 34.9% operating margin). Tiered add triggers are tightened to $84.50–$85.50 (tier 1) and $82.00–$82.85 (tier 2) with stop at $74.50, and explicit reassessment triggers are set at August 12 CPI print, Q3 2026 earnings, Berkshire 13F, and technical levels.

Outcome

✓

Return

+0.27%

Status

scored

Maintain HOLD on KO as the three-way analyst debate resolves to a bounded asymmetry — the bear needs catalysts (hot CPI, World Cup hangover, oil spike) while the bull needs everything aligned, but the franchise floor at $76.03 (200 SMA) caps downside and the macro regime (10Y at 4%+ vs KO 2.44% yield) caps upside. Trim 25-33% of position into any move above $88; deploy new capital only at $76-78 or on a post-CPI gap-down into $82-84 (50 SMA), with explicit reassessment triggers at the Aug 12 CPI print and Q3 2026 earnings in October.

Outcome

✓

Return

-0.45%

Status

scored

Analysts reached a HOLD consensus with a tiered add-on framework rather than binary buy/sell positions. Structural bull case (volume-led Q2 reacceleration, working capital noise in FCF, fortress balance sheet) wins on thesis, but conservative timing (26× trailing P/E, MACD exhaustion at 0.04, below-average volume on breakout attempts) wins on execution. Tier-1 adds are targeted at $85–86 on shallow retracement with volume confirmation; Tier-2 adds at $82–83 if 50 SMA holds as support.

Outcome

✓

Return

-0.21%

Status

scored

Maintain KO position at $87.05 with HOLD rating as the P/E at 26.14x sits 12-15% above historical norms, creating unfavorable entry-point arithmetic despite best-in-class margins (34.9% operating, 28.6% net, 42% ROE), $5.1B quarterly FCF, and supportive Goldilocks macro conditions. Permit a measured 25-33% starter add at current levels while preserving staged limit-buy orders at $86.40 and $82.40, with stop tightened to $83.40 (≈2 ATR) and reassessment at the August 12 CPI print or clean breakout above $90.92.